Nutriband Inc. (NTRBW)
NASDAQ: NTRBW
· Real-Time Price · USD
2.26
0.18 (8.65%)
At close: May 01, 2025, 3:48 PM
2.26
0.00%
After-hours: May 01, 2025, 04:00 PM EDT
8.65% (1D)
| Bid | 2.03 |
| Market Cap | 25.24M |
| Revenue (ttm) | 2.14M |
| Net Income (ttm) | -10.48M |
| EPS (ttm) | -0.505 |
| PE Ratio (ttm) | -4.48 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.54 |
| Volume | 26 |
| Avg. Volume (20D) | 5,920 |
| Open | 2.00 |
| Previous Close | 2.08 |
| Day's Range | 2.00 - 2.26 |
| 52-Week Range | 0.46 - 5.25 |
| Beta | 0.91 |
About NTRBW
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 1, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol NTRBW
Website http://nutriband.com